Patents by Inventor James Burke

James Burke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10445983
    Abstract: An artificial intelligence (AI) learning machine is integrated into a gaming system to adaptively learn to predict when and where excessive chronological clustering of winning hits is likely to occur for a progressive jackpot (e.g., a high frequency one) within the gaming system, to preemptively prepare for such occurrences by prefunding one or more smart-awards funds to cope with such excessive chronological clusterings of hits and to use the one or more smart-awards funds to pay off not-first-in-time winners with a same jackpot award amount as is paid to the true first-in-time winner of the jackpot if such runner up winners hit their respective win conditions within a predetermined smart-awards time span after the first-in-time winner hits. This can avoid or reduce feelings of unfairness by the not-first-in-time winners especially when the latter hit just a split second after the true first-in-time winner hits the jackpot.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: October 15, 2019
    Assignee: AGS LLC
    Inventors: Scott Andrew Melnick, Andrew James Burke, Anil Kumar Narra, Bradley Donald Schultz, Leah Anne Pinnow
  • Publication number: 20190254965
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 22, 2019
    Inventors: Michael R. Robinson, James A. Burke, Rhett M. Schiffman, Alazar N. Ghebremeskel
  • Patent number: 10363214
    Abstract: Compositions and methods for treating dry age related macular degeneration (dry AMO) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: July 30, 2019
    Assignee: Allergan, Inc.
    Inventors: Scott M. Whitcup, Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, James A. Burke
  • Publication number: 20190208259
    Abstract: Various arrangements for providing bimodal digital video recording are presented. A plurality of over-the-air (OTA) television programs received via an antenna input port may be recorded to a local processor-readable storage medium. Record instructions may be transmitted to a cloud-based television programming service provider server system to remotely record and store scheduled streaming television programs to storage of the cloud-based television programming service provider server system. OTA television programs received via the antenna input port and recorded to the local processor-readable storage medium may be determined. Indications of television programs stored by the cloud-based television programming service provider server system may be received. Data may be output to a display device to present the bimodal DVR interface having a unified interface that simultaneously comprises indications of the recorded OTA television programs and indications of the scheduled streaming television programming.
    Type: Application
    Filed: December 28, 2017
    Publication date: July 4, 2019
    Inventors: Jimshade Chaudhari, Joseph Puccio, James Burke O'Brien, IV, David London, Trent A Badger, James Kim
  • Publication number: 20190196839
    Abstract: A system and method for increasing address generation operations per cycle is described. In particular, a unified address generation scheduler queue (AGSQ) is a single queue structure which is accessed by first and second pickers in a picking cycle. Picking collisions are avoided by assigning a first set of entries to the first picker and a second set of entries to the second picker. The unified AGSQ uses a shifting, collapsing queue structure to shift other micro-operations into issued entries, which in turn collapses the queue and re-balances the unified AGSQ. A second level and delayed picker picks a third micro-operation that is ready for issue in the picking cycle. The third micro-operation is picked from the remaining entries across the first set of entries and the second set of entries. The third micro-operation issues in a next picking cycle.
    Type: Application
    Filed: December 22, 2017
    Publication date: June 27, 2019
    Applicant: Advanced Micro Devices, Inc.
    Inventors: Christopher Spence Oliver, Hanbing Liu, Christopher James Burke, Michael D. Achenbach
  • Publication number: 20190167858
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
    Type: Application
    Filed: February 11, 2019
    Publication date: June 6, 2019
    Inventors: Glenn T. Huang, Brittany Jackson, James A. Burke, Ton Lin, Patrick M. Hughes, Larry A. Wheeler, Rosy Sheng Donn
  • Patent number: 10278919
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: May 7, 2019
    Assignee: Allergan, Inc.
    Inventors: Michael R. Robinson, James A. Burke, Rhett M Schiffman, Alazar N. Ghebremeskel
  • Publication number: 20190050452
    Abstract: A computer system receives a query and converts the query into one or more input data types each associated with a respective piece of input constraint data, and one or more output datatypes corresponding to desired data. A data path workflow scheme is created from the datatypes and a catalog of data path modules each of which has defined datatype of its input(s) and output(s) by building candidate data paths forward from the input and rearward from the output of the data path until data paths from all of the outputs connect with at least one of the data path inputs. The data path is then optimized and converted to an executable code data procedure and then run with the constraint data as the input to the procedure. The results can be displayed to a user display device by presentation modules based on the datatype of the output.
    Type: Application
    Filed: August 14, 2017
    Publication date: February 14, 2019
    Inventors: Christopher Milroy, Paul Vogel, John Sahlin, Christopher Waychoff, James Burke, Fred Frantz, Adam Whitlock
  • Patent number: 10201641
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: February 12, 2019
    Assignee: Allergan, Inc.
    Inventors: Glenn T. Huang, Brittany Jackson, James A. Burke, Ton Lin, Patrick M. Hughes, Larry A. Wheeler, Rosy Sheng Donn
  • Patent number: 10157287
    Abstract: A secure access client can be employed to enforce limitations on a user's access to a file while also allowing the user to access the file using an application of choice. To provide this functionality, the secure access client can implement an RDP client that is configured to create an RDP session with an RDP service executing on the same computing device. The RDP service can allow the secure access client to display the user interface of an application employed to open a file. The secure access client can be configured to selectively apply access limitations on a per file basis. This selective enforcement can be accomplished by only implementing a virtual channel extension to provide a particular type of access to the file when the file's access limitations would allow such access.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: December 18, 2018
    Assignee: Wyse Technology L.L.C.
    Inventors: Andrew Fausak, Oleg Rombakh, James Burke, Darrell Testerman, Chris Burchett, Warren Robbins
  • Patent number: 10086320
    Abstract: An apparatus and method are provided that enable the control of a screening operation based on a calculated screen blockage percentage and the velocity throughput of the screen. The apparatus includes an upstream level detector, a downstream level detector and flume or weir placed downstream of the screen. The apparatus may further include a blockage determination unit which determines the percent screen blockage based on the flow level upstream of the screen and the flow level downstream of the screen.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: October 2, 2018
    Assignee: JWC Environmental, LLC
    Inventors: Scott Kelly, Kenneth Oyler, James Burke
  • Publication number: 20170298791
    Abstract: An engine includes a block containing multiple valves, and a camshaft defining multiple cams for rotation about a camshaft axis. A valve lift assembly is operatively associated with a respective one of the cams and a respective one of the valves to transfer motion from the cam to the valve by reciprocal motion of the valve lift assembly along a lift axis. The assembly includes a follower and a follower control mechanism. The follower is disposed in contact with the cam at a contact point that defines a contact path extending along a surface of the cam as the cam rotates about the camshaft axis. The follower is moveable through an adjustment range to change the position of the contact point along the contact path at a given angular position of the cam. The follower control mechanism is operable to control the movement of the follower within the adjustment range.
    Type: Application
    Filed: April 15, 2016
    Publication date: October 19, 2017
    Applicant: Caterpillar Inc.
    Inventors: Eric C. Fluga, Eric Donald Wiebrecht, Kerry Alan DelVecchio, Logan James Burke
  • Publication number: 20170228551
    Abstract: A secure access client can be employed to enforce limitations on a user's access to a file while also allowing the user to access the file using an application of choice. To provide this functionality, the secure access client can implement an RDP client that is configured to create an RDP session with an RDP service executing on the same computing device. The RDP service can allow the secure access client to display the user interface of an application employed to open a file. The secure access client can be configured to selectively apply access limitations on a per file basis. This selective enforcement can be accomplished by only implementing a virtual channel extension to provide a particular type of access to the file when the file's access limitations would allow such access.
    Type: Application
    Filed: February 9, 2016
    Publication date: August 10, 2017
    Inventors: Andrew Fausak, Oleg Rombakh, James Burke, Darrell Testerman, Chris Burchett, Warren Robbins
  • Publication number: 20170198045
    Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multichain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.
    Type: Application
    Filed: May 29, 2015
    Publication date: July 13, 2017
    Applicant: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Gurunadh Reddy Chichili, Kalpana Shah, Chia-Ying Kao Lam, Stephen James Burke, Liqin Liu, Paul A. Moore, Ezio Bonvini, Bhaswati Barat
  • Patent number: 9622409
    Abstract: A reciprocating knife assembly of an agricultural implement includes first and second elongate reciprocating knives disposed along a leading edge of an agricultural implement, the reciprocating knives being disposed end to end and extending colinearly for simultaneous reciprocation in opposite directions, the first and second reciprocating knives being supported for sliding movement on the agricultural implement in a lateral direction generally perpendicular to the direction of travel of the agricultural implement as it travels through an agricultural field harvesting crop, a first bell crank coupled to the first reciprocating knife to reciprocate said knife, a second bell crank coupled to the second reciprocating knife to reciprocate the second reciprocating knife, and a common drive coupled to the first and second bell cranks to drive both the first and second bell cranks in opposite directions simultaneously.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: April 18, 2017
    Assignee: Deere & Company
    Inventors: Bruce Alan Coers, Daniel James Burke, Ryan Patrick Mackin, James Kelley Adamson, Mark L. Pearson
  • Publication number: 20170071853
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Application
    Filed: November 28, 2016
    Publication date: March 16, 2017
    Inventors: Michael R. Robinson, James A. Burke, Rhett M Schiffman, Alazar N. Ghebremeskel
  • Patent number: 9572859
    Abstract: Compositions, and methods of using such compositions, useful for injection into the posterior segments of human or animal eyes are provided. Such compositions include small particles of a poorly soluble therapeutic agent that facilitates formation of concentrated regions of the therapeutic agent in the retinal pigmented epithelium of an eye. The particles are formed by combining a therapeutic agent with an ophthalmically acceptable polymer component. The particles have sizes less than about 3000 nanometers, and in some cases, less than about 200 nanometers. One example of a composition includes particles of triamcinolone acetonide and hyaluronic acid have a size less than about 3000 nanometers.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: February 21, 2017
    Assignee: Allergan, Inc.
    Inventors: Patrick M. Hughes, Orest Olejnik, Scott M. Whitcup, James A. Burke
  • Patent number: 9514116
    Abstract: Gadgets integrate with spreadsheets and the spreadsheet calculation engine. A gadget is bound to a range of cells (one or more) within a sheet. When one or more of the cells of the bound range is accessed (e.g. selected, hovered over, edited, deleted, added), the gadget is notified. The gadget may use this information for updating a display rendered by the gadget and/or performing some other action. The gadget uses an Application Programming Interface (API) to create the binding, communicate with the spreadsheet, and perform actions in the spreadsheet. The gadget is a Named Item object within the spreadsheet such that the gadget may be viewed/displayed differently from other objects. Out of date requests from the gadget are attempted to be detected and prevented from being processed such that the gadget is not acting on the latest data.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: December 6, 2016
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Lawrence Waldman, Keyur Rahul Patel, Sharar Prish, Eoin James Burke, Daniel Battagin, Jon Garrett Simmons
  • Patent number: 9504696
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: November 29, 2016
    Assignee: Allergan, Inc.
    Inventors: Michael R. Robinson, James A. Burke, Rhett M. Schiffman, Alazar N. Ghebremeskel
  • Publication number: 20160256382
    Abstract: The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal administration to a patient with elevated intraocular pressure (IOP), said implant comprising a core of an antihypertensive agent surrounded by a polymer, which limits the rate of passage of the antihypertensive agent from the implant into the eye of said patient and said implant provides a linear rate of release of therapeutically effective amounts of said anti-hypertensive agent into the eye for a period of time of between 14 days and 365 days.
    Type: Application
    Filed: May 19, 2016
    Publication date: September 8, 2016
    Inventors: Ruiwen Shi, Patrick M. Hughes, James A. Burke, Michael R. Robinson, Hui Liu